Veterinary Molecular Diagnostic Market Research Report by Product (Instruments & Software, Kits & Reagent, and Services), by Technology (DNA Sequencing, Microarrays, and Polymerase Chain Reaction), by Animal Type, by Disease Indication, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

 

The Global Veterinary Molecular Diagnostic Market is expected to grow from USD 415.87 Million in 2019 to USD 664.88 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.13%.

 

 

This research report categorizes the Veterinary Molecular Diagnostic to forecast the revenues and analyze the trends in each of the following sub-markets:

 

Based on Product, the Veterinary Molecular Diagnostic Market studied across Instruments & Software, Kits & Reagent, and Services.

 

Based on Technology, the Veterinary Molecular Diagnostic Market studied across DNA Sequencing, Microarrays, and Polymerase Chain Reaction.

 

Based on Animal Type, the Veterinary Molecular Diagnostic Market studied across Companion Animal and Livestock Animal. The Companion Animal further studied across Canine, Equine, and Feline. The Livestock Animal further studied across Bovine, Ovine or Caprine, Porcine, and Poultry.

 

Based on Disease Indication, the Veterinary Molecular Diagnostic Market studied across Diarrhea Pathogens Detection, Respiratory Pathogens Detection, and Vector Borne Diseases.

 

Based on End User, the Veterinary Molecular Diagnostic Market studied across Hospitals or Clinics and Reference Laboratories.

 

Based on Geography, the Veterinary Molecular Diagnostic Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

 

 

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Veterinary Molecular Diagnostic Market including Abaxis, Inc., Biomedica Medizinprodukte GmbH, Bioneer, HealthGene Corporation, IDEXX Laboratories, Inc., Neogen Corporation, Novacyt Group, QIAGEN N.V., Thermo Fisher Scientific, Inc., and VCA, Inc..

 

 

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Veterinary Molecular Diagnostic Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

 

Competitive Strategic Window:

 

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

 

 

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

 

 

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

 

 

1. What is the market size and forecast of the Global Veterinary Molecular Diagnostic Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Veterinary Molecular Diagnostic Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Veterinary Molecular Diagnostic Market?

4. What is the competitive strategic window for opportunities in the Global Veterinary Molecular Diagnostic Market?

5. What are the technology trends and regulatory frameworks in the Global Veterinary Molecular Diagnostic Market?

6. What are the modes and strategic moves considered suitable for entering the Global Veterinary Molecular Diagnostic Market?

1.1. Objectives of the Study

1.2. Market Segmentation & Coverage

1.3. Years Considered for the Study

1.4. Currency & Pricing

1.5. Language

1.6. Stakeholders

2.1. Research Process

2.1.1. Define: Research Objective

2.1.2. Determine: Research Design

2.1.3. Prepare: Research Instrument

2.1.4. Collect: Data Source

2.1.5. Analyze: Data Interpretation

2.1.6. Formulate: Data Verification

2.1.7. Publish: Research Report

2.1.8. Repeat: Report Update

2.2. Research Execution

2.2.1. Initiation: Research Process

2.2.2. Planning: Develop Research Plan

2.2.3. Execution: Conduct Research

2.2.4. Verification: Finding & Analysis

2.2.5. Publication: Research Report

2.3. Research Outcome

3.1. Market Outlook

3.2. Product Outlook

3.3. Technology Outlook

3.4. Animal Type Outlook

3.5. Disease Indication Outlook

3.6. End User Outlook

3.7. Geography Outlook

3.8. Competitor Outlook

4.1. Introduction

5.1. Introduction

5.2. Drivers

5.3. Restraints

5.4. Opportunities

5.5. Challenges

6.1. Porters Five Forces Analysis

6.1.1. Threat of New Entrants

6.1.2. Threat of Substitutes

6.1.3. Bargaining Power of Customers

6.1.4. Bargaining Power of Suppliers

6.1.5. Industry Rivalry

6.2. Cumulative Impact of COVID-19

6.3. Client Customizations

7.1. Introduction

7.2. Instruments & Software

7.3. Kits & Reagent

7.4. Services

8.1. Introduction

8.2. DNA Sequencing

8.3. Microarrays

8.4. Polymerase Chain Reaction

9.1. Introduction

9.2. Companion Animal

9.2.1. Canine

9.2.2. Equine

9.2.3. Feline

9.3. Livestock Animal

9.3.1. Bovine

9.3.2. Ovine or Caprine

9.3.3. Porcine

9.3.4. Poultry

10.1. Introduction

10.2. Diarrhea Pathogens Detection

10.3. Respiratory Pathogens Detection

10.4. Vector Borne Diseases

11.1. Introduction

11.2. Hospitals or Clinics

11.3. Reference Laboratories

12.1. Introduction

12.2. Americas

12.2.1. Argentina

12.2.2. Brazil

12.2.3. Canada

12.2.4. Mexico

12.2.5. United States

12.3. Asia-Pacific

12.3.1. Australia

12.3.2. China

12.3.3. India

12.3.4. Indonesia

12.3.5. Japan

12.3.6. Malaysia

12.3.7. Philippines

12.3.8. South Korea

12.3.9. Thailand

12.4. Europe, Middle East & Africa

12.4.1. France

12.4.2. Germany

12.4.3. Italy

12.4.4. Netherlands

12.4.5. Qatar

12.4.6. Russia

12.4.7. Saudi Arabia

12.4.8. South Africa

12.4.9. Spain

12.4.10. United Arab Emirates

12.4.11. United Kingdom

13.1. Introduction

13.2. 360iResearch Competitive Strategic Window, by Product

13.3. 360iResearch Competitive Strategic Window, by Technology

13.4. 360iResearch Competitive Strategic Window, by Animal Type

13.5. 360iResearch Competitive Strategic Window, by Disease Indication

13.6. 360iResearch Competitive Strategic Window, by End User

13.7. 360iResearch Competitive Strategic Window, by Geography

14.1. 360iResearch FPNV Positioning Matrix

14.1.1. Quadrants

14.1.2. Business Strategy

14.1.3. Product Satisfaction

14.2. 360iResearch Market Ranking Analysis

14.3. 360iResearch Market Share Analysis

14.4. 360iResearch Competitive Scenario

14.4.1. Merger & Acquisition

14.4.2. Agreement, Collaboration, & Partnership

14.4.3. New Product Launch & Enhancement

14.4.4. Investment & Funding

14.4.5. Award, Recognition, & Expansion

15.1. Abaxis, Inc.

15.2. Biomedica Medizinprodukte GmbH

15.3. Bioneer

15.4. HealthGene Corporation

15.5. IDEXX Laboratories, Inc.

15.6. Neogen Corporation

15.7. Novacyt Group

15.8. QIAGEN N.V.

15.9. Thermo Fisher Scientific, Inc.

15.10. VCA, Inc.

16.1. Discussion Guide

16.2. Edition Details

16.3. License Details

16.4. Pricing Details

TABLE 1. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2017-2025 (USD MILLION)

TABLE 2. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 3. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 4. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY KITS & REAGENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 5. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY SERVICES, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 6. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 7. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DNA SEQUENCING, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 8. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY MICROARRAYS, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 9. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 10. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 11. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 12. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CANINE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 13. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY EQUINE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 14. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY FELINE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 15. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 16. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY BOVINE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 17. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY OVINE OR CAPRINE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 18. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PORCINE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 19. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY POULTRY, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 20. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 21. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DIARRHEA PATHOGENS DETECTION, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 22. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY RESPIRATORY PATHOGENS DETECTION, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 23. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY VECTOR BORNE DISEASES, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 24. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 25. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY HOSPITALS OR CLINICS, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 26. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REFERENCE LABORATORIES, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 27. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 28. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 29. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 30. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 31. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 32. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 33. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 34. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 35. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 36. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 37. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 38. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 39. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 40. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 41. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 42. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 43. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 44. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 45. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 46. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 47. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 48. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 49. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 50. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 51. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 52. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 53. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 54. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 55. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 56. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 57. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 58. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 59. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 60. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 61. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 62. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 63. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 64. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 65. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 66. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 67. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 68. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 69. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 70. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 71. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 72. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 73. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 74. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 75. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 76. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 77. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 78. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 79. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 80. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 81. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 82. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 83. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 84. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 85. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 86. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 87. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 88. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 89. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 90. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 91. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 92. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 93. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 94. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 95. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 96. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 97. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 98. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 99. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 100. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 101. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 102. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 103. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 104. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 105. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 106. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 107. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 108. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 109. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 110. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 111. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 112. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 113. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 114. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 115. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 116. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 117. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 118. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 119. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 120. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 121. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 122. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 123. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 124. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 125. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 126. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 127. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 128. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 129. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 130. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 131. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 132. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 133. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 134. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 135. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 136. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 137. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 138. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 139. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 140. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 141. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 142. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 143. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 144. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 145. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 146. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 147. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 148. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 149. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 150. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 151. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 152. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 153. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 154. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 155. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 156. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 157. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 158. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 159. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 160. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 161. UNITED ARAB EMIRATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 162. UNITED ARAB EMIRATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 163. UNITED ARAB EMIRATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 164. UNITED ARAB EMIRATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 165. UNITED ARAB EMIRATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 166. UNITED KINGDOM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 167. UNITED KINGDOM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)

TABLE 168. UNITED KINGDOM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2017-2025 (USD MILLION)

TABLE 169. UNITED KINGDOM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2017-2025 (USD MILLION)

TABLE 170. UNITED KINGDOM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 171. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET: SCORES

TABLE 172. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET: BUSINESS STRATEGY

TABLE 173. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET: PRODUCT SATISFACTION

TABLE 174. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET: RANKING

TABLE 175. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET: MERGER & ACQUISITION

TABLE 176. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP

TABLE 177. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT

TABLE 178. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET: INVESTMENT & FUNDING

TABLE 179. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET: AWARD, RECOGNITION, & EXPANSION

TABLE 180. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET: EDITION DETAILS

TABLE 181. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET: LICENSE DETAILS

TABLE 182. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET: PRICING DETAILS